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Summary 25
Background: Successful laboratory detection of carbapenemase-producing Enterobacteriaceae (CPE) 26 in patient surveillance samples is a diagnostic challenge. In the absence of a gold standard to use for 27 screening rectal swabs for CPE, many phenotypic, genotypic, culture and non-culture based assays 28 have been proposed for identifying these bacteria. 29
Aim: To develop and optimise a CPE screening protocol capable of identifying all commonly 30 encountered CPE, including those producing OXA-48-like carbapenemases 31
Methods: Faropenem (CAT-ID) susceptibility was performed on 507 presumptive CPE isolated from 32 diagnostic samples and CPE rectal screens between March and August 2016. Results from this CPE 33 screening method were compared to those from direct culture on mSuperCARBA TM , temocillin 34 enrichment culture and use of an antibiotic resistance algorithm, to determine the optimal method 35 to employ in the detection of CPE. 36
Findings: Faropenem was a poor predictor of carbapenemase production (58% true positives)The 37 combination of a temocillin enrichment stage and interpretitve reading of antibiotic resistance 38 phenotypes improved the recovery and identification of CPE significantly (91% true-positives), 39
Introduction 51
Acquired resistance to carbapenems in Enterobacteriaceae is a global problem facilitated by 52 plasmid-mediated spread of class A (KPC), B (IMP, VIM, NDM) and D (OXA-48-like) β-lactamases 53 among multiple species (E. coli, Klebsiella, Enterobacter, Citrobacter species). In the UK, there are 54 reports of hospital outbreaks which are increasingly difficult to control and also overlap with spread 55 into and within the community. [1] [2] [3] [4] 56 57 Accurate detection of carbapenemase-producing Enterobacteriaceae (CPE) is fundamental to any 58 strategy aimed at addressing this problem. Many methods have been used to identify CPE including 59 phenotypic susceptibility tests, selective culture media, immunochromatographic assays, specific 60
PCRs and sequenced based molecular tests; all with varying degrees of sensitivity and specificity. GmbH, Bremen, Germany). 84
Urinary isolates underwent faropenem susceptibility testing if they were resistant to cefpodoxime 85 (BSAC disc diffusion) and all other isolates from other diagnostic specimens underwent faropenem 86 susceptibility testing if they were reported resistant to ≥1 carbapenem using the Microscan Due to an OXA-48 outbreak in a surgical ward (June 2016 -current), direct culture was compared to 112 temocillin enrichment culture. Enrichment culture was specifically designed to recover OXA-48-113 producers, in addition to all other CPE. 114
Rectal swabs (n = 95) were inoculated into 3 ml nutrient broth (Thermo Scientific TM Oxoid TM ) 115 containing a temocillin (30µg) disc. After overnight incubation at 37°C turbid broths were sub-116 cultured to mSuperCARBA TM . Broths were set up in tandem with direct culture to assess the 117 advantages of enrichment culture and compared using a paired t-test, with a p-value ≤0.05 118 considered significant. Enterobacteriaceae were identified and underwent AST, as described above. 119
120

CPE algorithm 121
Identification of CPE was reported using an algorithm-based approach and the following interpretive 122 rules: 1) Enterobacteriaceae resistant to meropenem and ertapenem, irrespective of other AST 123 results, were reported as presumptive CPE; 2) Enterobacteriaceae resistant to temocillin and 124 piperacillin-tazobactam, but susceptible to meropenem, were reported as presumptive OXA-48. Together these results suggest a true-positive rate of 58%, a false-positive rate of 77% and an 145 approximate false-negative rate of 2% for faropenem disc testing for he detection of CPE. 146
147
As faropenem susceptibility was deemed a poor predictor of carbapenemase production, AST results 148 were reviewed to identify possible indicator antibiotics (Table I ). All three NDM isolates were 149 resistant to meropenem, ertapenem and piperacillin-tazobactam and 2/3 were temocillin-resistant. 150
All twenty-one OXA-48 producers were temocillin-resistant and 20/21 (95%) were also resistant to 151 piperacillin-tazobactam. Only 2/21 (10%) OXA-48 producers were meropenem-resistant and only 152 11/21 (52%) were ertapenem-resistant. These findings informed a resistance algorithm with two 153 phenotypic groups for isolates recovered on mSuperCARBA TM . Group 1: isolates with resistance to 154 meropenem and ertapenem were reported as presumptive CPE; group 2: isolates with resistance to 155 temocillin and piperacillin-tazobactam were reported as presumptive OXA-48 producers. In our experience, accurate detection of OXA-48, the predominant carbapenemase in our institution, 177 has been a significant problem. The initial approach combining selective chromogenic media 178 (mSuperCARBA TM ) with faropenem resistance (CAT-ID discs) appeared sub-optimal. Despite reports 179 of faropenem performing well, we found it to be a poor predictor of OXA-48 producers (58% true-180 positives).
8, 11 Similarly Koroska et al (2017) demonstrated a sensitivity of only 57.1% when using 181
CAT-ID to explicitly identify OXA-48. 6 In addition, our OXA-48 producers were typically meropenem 182 and ertapenem susceptible (table I) in contrast to previous studies with only carbapenem-resistant 183 isolates, demonstrating that resistance to faropenem alone may miss many OXA-48 producers. Other studies have proposed diagnostic algorithms for CPE screening; employing faropenem and 206 temocillin susceptibility to differentiate non-CPE, CPE and OXA-48 producers.
6, 11 While they show 207 that a combination of methods increases the sensitivity of CPE detection, there are also 208 disadvantages. One relied on reduced carbapenem susceptibility to trigger a confirmatory CPE test 209 (CAT-ID), which isunlikely to be practical if the majority of OXA-48 producers are carbapenem 210 susceptible.
11 Another study detected OXA-48 using a lateral flow device (LFD) to compensate for 211 the poor performance of faropenem.
6 While simple and rapid, LFD devices capable of detecting 212 carbapenemases also increase CPE screening costs and may limit widespread use in high-throughput 213 diagnostic laboratories. 214
215
We have developed a robust and affordable protocol for identifying CPE from rectal swabs, which 216 has the flexibility of identifying carbapenemases in isolates with variable susceptibility to β-lactams, 217
including OXA-48. The inclusion of a temocillin enrichment step combined with an algorithm-based 218 interpretation of AST results enabled detection of all CPE from rectal screens with a high degree of 219 accuracy. The algorithm enabled us to harmonise differing methodologies used in carbapenem 220 susceptibility testing and CPE screening into a single protocol able to inform both treatment and 221 infection prevention and control strategies. 222 223
